Sangamo Therapeutics, Inc.
|
-257.83 Million USD
|
96.819%
|
IDEAYA Biosciences, Inc.
|
-112.96 Million USD
|
92.739%
|
Eton Pharmaceuticals, Inc.
|
-936 Thousand USD
|
-776.25%
|
Autolus Therapeutics plc
|
-208.38 Million USD
|
96.064%
|
Greenwich LifeSciences, Inc.
|
-8.89 Million USD
|
7.761%
|
Enlivex Therapeutics Ltd.
|
-29.06 Million USD
|
71.784%
|
Shattuck Labs, Inc.
|
-87.29 Million USD
|
90.605%
|
LENZ Therapeutics, Inc.
|
-124.65 Million USD
|
93.42%
|
CervoMed Inc.
|
-2.17 Million USD
|
-277.633%
|
Rocket Pharmaceuticals, Inc.
|
-245.59 Million USD
|
96.66%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-44.6 Million USD
|
81.612%
|
Aptose Biosciences Inc.
|
-51.2 Million USD
|
83.983%
|
Precision BioSciences, Inc.
|
-61.31 Million USD
|
86.625%
|
Dyadic International, Inc.
|
-6.79 Million USD
|
-20.694%
|
TScan Therapeutics, Inc.
|
-89.21 Million USD
|
90.807%
|
Intensity Therapeutics, Inc.
|
-10.53 Million USD
|
22.17%
|
Nektar Therapeutics
|
-276.05 Million USD
|
97.029%
|
CytomX Therapeutics, Inc.
|
-569 Thousand USD
|
-1341.424%
|
VYNE Therapeutics Inc.
|
-28.45 Million USD
|
71.174%
|
EyePoint Pharmaceuticals, Inc.
|
-70.79 Million USD
|
88.415%
|
Leap Therapeutics, Inc.
|
-81.41 Million USD
|
89.926%
|
Adaptive Biotechnologies Corporation
|
-225.25 Million USD
|
96.359%
|
GRI Bio, Inc.
|
-13.03 Million USD
|
37.089%
|
Xenetic Biosciences, Inc.
|
-4.13 Million USD
|
-98.369%
|
Tenaya Therapeutics, Inc.
|
-124.08 Million USD
|
93.39%
|
NeuroSense Therapeutics Ltd.
|
-10.1 Million USD
|
18.851%
|
Psyence Biomedical Ltd.
|
-51.15 Million USD
|
83.968%
|
IGM Biosciences, Inc.
|
-246.41 Million USD
|
96.672%
|
INmune Bio, Inc.
|
-30 Million USD
|
72.668%
|
Opthea Limited
|
-220.24 Million USD
|
96.276%
|
Milestone Pharmaceuticals Inc.
|
-59.68 Million USD
|
86.258%
|
Omega Therapeutics, Inc.
|
-97.42 Million USD
|
91.582%
|
Verastem, Inc.
|
-87.36 Million USD
|
90.612%
|
Abeona Therapeutics Inc.
|
-54.18 Million USD
|
84.864%
|
Pliant Therapeutics, Inc.
|
-161.33 Million USD
|
94.916%
|
Tonix Pharmaceuticals Holding Corp.
|
-116.65 Million USD
|
92.969%
|
Ligand Pharmaceuticals Incorporated
|
52.15 Million USD
|
115.726%
|
NextCure, Inc.
|
-62.72 Million USD
|
86.924%
|
Inhibikase Therapeutics, Inc.
|
-19.02 Million USD
|
56.899%
|
Organovo Holdings, Inc.
|
-14.67 Million USD
|
44.096%
|
Lixte Biotechnology Holdings, Inc.
|
-5.08 Million USD
|
-61.228%
|
Arvinas, Inc.
|
-367.3 Million USD
|
97.767%
|
Ovid Therapeutics Inc.
|
-52.33 Million USD
|
84.33%
|
CASI Pharmaceuticals, Inc.
|
-26.93 Million USD
|
69.553%
|
Rani Therapeutics Holdings, Inc.
|
-33.97 Million USD
|
75.856%
|
Centessa Pharmaceuticals plc
|
-151.08 Million USD
|
94.571%
|
Arcturus Therapeutics Holdings Inc.
|
-29.72 Million USD
|
72.408%
|
Syros Pharmaceuticals, Inc.
|
-164.57 Million USD
|
95.016%
|
Senti Biosciences, Inc.
|
-92.91 Million USD
|
91.173%
|
BioRestorative Therapies, Inc.
|
-10.41 Million USD
|
21.271%
|
Apollomics, Inc.
|
-172.6 Million USD
|
95.248%
|
PureTech Health plc
|
-65.69 Million USD
|
87.516%
|
Oncternal Therapeutics, Inc.
|
-39.47 Million USD
|
79.225%
|
Barinthus Biotherapeutics plc
|
-73.34 Million USD
|
88.818%
|
Kymera Therapeutics, Inc.
|
-146.96 Million USD
|
94.419%
|
Synaptogenix, Inc.
|
-6.03 Million USD
|
-35.823%
|
ChromaDex Corporation
|
-4.93 Million USD
|
-66.094%
|
Beam Therapeutics Inc.
|
-132.52 Million USD
|
93.811%
|
Monopar Therapeutics Inc.
|
-8.4 Million USD
|
2.386%
|
Akebia Therapeutics, Inc.
|
-51.92 Million USD
|
84.205%
|
Nurix Therapeutics, Inc.
|
-143.94 Million USD
|
94.302%
|
Apellis Pharmaceuticals, Inc.
|
-528.62 Million USD
|
98.448%
|
Dermata Therapeutics, Inc.
|
-7.79 Million USD
|
-5.222%
|
Gritstone bio, Inc.
|
-138.49 Million USD
|
94.078%
|
Mesoblast Limited
|
-87.95 Million USD
|
90.675%
|
Virpax Pharmaceuticals, Inc.
|
-15.18 Million USD
|
46.004%
|
Xeris Biopharma Holdings, Inc.
|
-62.25 Million USD
|
86.826%
|
Fate Therapeutics, Inc.
|
-160.92 Million USD
|
94.903%
|
MediWound Ltd.
|
-6.71 Million USD
|
-22.122%
|
BioXcel Therapeutics, Inc.
|
-179.05 Million USD
|
95.419%
|
Fortress Biotech, Inc.
|
-60.63 Million USD
|
86.474%
|
Fractyl Health, Inc. Common Stock
|
-77.09 Million USD
|
89.361%
|
Achilles Therapeutics plc
|
-69.66 Million USD
|
88.227%
|
Seres Therapeutics, Inc.
|
-113.72 Million USD
|
92.788%
|
Checkpoint Therapeutics, Inc.
|
-51.84 Million USD
|
84.181%
|
Atossa Therapeutics, Inc.
|
-30.09 Million USD
|
72.746%
|
Zai Lab Limited
|
-334.62 Million USD
|
97.549%
|
Fresh Tracks Therapeutics, Inc.
|
-5.69 Million USD
|
-44.041%
|
Lyell Immunopharma, Inc.
|
-234.63 Million USD
|
96.504%
|
Vanda Pharmaceuticals Inc.
|
2.5 Million USD
|
426.891%
|
Tarsus Pharmaceuticals, Inc.
|
-135.89 Million USD
|
93.965%
|
InMed Pharmaceuticals Inc.
|
-7.67 Million USD
|
-6.855%
|
FibroGen, Inc.
|
-284.23 Million USD
|
97.114%
|
Celcuity Inc.
|
-63.77 Million USD
|
87.14%
|
SeaStar Medical Holding Corporation
|
-26.23 Million USD
|
68.734%
|
ContextLogic Inc.
|
-317 Million USD
|
97.413%
|
GH Research PLC
|
-35.58 Million USD
|
76.953%
|
HOOKIPA Pharma Inc.
|
-81.58 Million USD
|
89.946%
|
Cyclacel Pharmaceuticals, Inc.
|
-22.55 Million USD
|
63.637%
|
ImmuCell Corporation
|
-5.77 Million USD
|
-42.031%
|
Amylyx Pharmaceuticals, Inc.
|
49.27 Million USD
|
116.646%
|
Amarin Corporation plc
|
-59.11 Million USD
|
86.125%
|
TG Therapeutics, Inc.
|
12.67 Million USD
|
164.723%
|
Aptevo Therapeutics Inc.
|
-17.41 Million USD
|
52.894%
|
Jasper Therapeutics, Inc.
|
-64.46 Million USD
|
87.277%
|
Foghorn Therapeutics Inc.
|
-98.42 Million USD
|
91.667%
|
Y-mAbs Therapeutics, Inc.
|
-21.42 Million USD
|
61.723%
|
Aptorum Group Limited
|
-2.82 Million USD
|
-190.362%
|
Ultragenyx Pharmaceutical Inc.
|
-606.63 Million USD
|
98.648%
|
BioCryst Pharmaceuticals, Inc.
|
-226.53 Million USD
|
96.38%
|
Chemomab Therapeutics Ltd.
|
-24.22 Million USD
|
66.138%
|
Arrowhead Pharmaceuticals, Inc.
|
-205.27 Million USD
|
96.005%
|
TransCode Therapeutics, Inc.
|
-18.54 Million USD
|
55.777%
|
RAPT Therapeutics, Inc.
|
-116.79 Million USD
|
92.978%
|
Ardelyx, Inc.
|
-66.06 Million USD
|
87.586%
|
Ainos, Inc.
|
-13.77 Million USD
|
40.44%
|
Lyra Therapeutics, Inc.
|
-62.68 Million USD
|
86.915%
|
Prothena Corporation plc
|
-147.02 Million USD
|
94.422%
|
HilleVax, Inc.
|
-123.56 Million USD
|
93.362%
|
Adaptimmune Therapeutics plc
|
-113.87 Million USD
|
92.797%
|
Celularity Inc.
|
-196.29 Million USD
|
95.822%
|
Rallybio Corporation
|
-74.56 Million USD
|
89.0%
|
Cue Biopharma, Inc.
|
-50.73 Million USD
|
83.834%
|
Omeros Corporation
|
-117.81 Million USD
|
93.038%
|
Humacyte, Inc.
|
-110.77 Million USD
|
92.596%
|
Immunocore Holdings plc
|
-55.28 Million USD
|
85.165%
|
Cocrystal Pharma, Inc.
|
-17.98 Million USD
|
54.394%
|
Blueprint Medicines Corporation
|
-506.98 Million USD
|
98.382%
|
IO Biotech, Inc.
|
-86.08 Million USD
|
90.472%
|
MEI Pharma, Inc.
|
17.77 Million USD
|
146.134%
|
GT Biopharma, Inc.
|
-7.59 Million USD
|
-7.96%
|
Cabaletta Bio, Inc.
|
-67.67 Million USD
|
87.881%
|
Summit Therapeutics Inc.
|
-614.92 Million USD
|
98.666%
|
Alaunos Therapeutics, Inc.
|
-35.14 Million USD
|
76.66%
|
Marinus Pharmaceuticals, Inc.
|
-141.4 Million USD
|
94.2%
|
Scholar Rock Holding Corporation
|
-165.78 Million USD
|
95.053%
|
Pulmatrix, Inc.
|
-14.12 Million USD
|
41.918%
|
Elicio Therapeutics, Inc.
|
-35.19 Million USD
|
76.696%
|
X4 Pharmaceuticals, Inc.
|
-101.16 Million USD
|
91.893%
|
Vigil Neuroscience, Inc.
|
-82.63 Million USD
|
90.075%
|
Acelyrin, Inc.
|
-381.64 Million USD
|
97.851%
|
Intellia Therapeutics, Inc.
|
-481.19 Million USD
|
98.296%
|
Cytokinetics, Incorporated
|
-526.24 Million USD
|
98.441%
|
Vor Biopharma Inc.
|
-117.86 Million USD
|
93.041%
|
Evogene Ltd.
|
-23.87 Million USD
|
65.653%
|
Replimune Group, Inc.
|
-215.79 Million USD
|
96.199%
|
Applied Therapeutics, Inc.
|
-119.76 Million USD
|
93.152%
|
PDS Biotechnology Corporation
|
-42.94 Million USD
|
80.901%
|
Hoth Therapeutics, Inc.
|
-7.84 Million USD
|
-4.542%
|
BridgeBio Pharma, Inc.
|
-643.2 Million USD
|
98.725%
|
AEON Biopharma, Inc.
|
-52.55 Million USD
|
84.394%
|
BioLineRx Ltd.
|
-60.61 Million USD
|
86.469%
|
Galectin Therapeutics Inc.
|
-41.06 Million USD
|
80.028%
|
Atai Life Sciences N.V.
|
-40.22 Million USD
|
79.61%
|
Aerovate Therapeutics, Inc.
|
-75.52 Million USD
|
89.14%
|
VistaGen Therapeutics, Inc.
|
-29.36 Million USD
|
72.067%
|
Zentalis Pharmaceuticals, Inc.
|
-292.19 Million USD
|
97.193%
|
Sagimet Biosciences Inc.
|
-27.87 Million USD
|
70.578%
|
MediciNova, Inc.
|
-8.57 Million USD
|
4.314%
|
Praxis Precision Medicines, Inc.
|
-123.27 Million USD
|
93.347%
|
MiMedx Group, Inc.
|
67.43 Million USD
|
112.162%
|
Cardio Diagnostics Holdings, Inc.
|
-8.37 Million USD
|
2.091%
|
Axsome Therapeutics, Inc.
|
-239.23 Million USD
|
96.572%
|
PTC Therapeutics, Inc.
|
-626.6 Million USD
|
98.691%
|
Mereo BioPharma Group plc
|
-29.46 Million USD
|
72.166%
|
Syndax Pharmaceuticals, Inc.
|
-209.36 Million USD
|
96.082%
|
NRx Pharmaceuticals, Inc.
|
-30.15 Million USD
|
72.797%
|
Dyne Therapeutics, Inc.
|
-235.93 Million USD
|
96.524%
|
BriaCell Therapeutics Corp.
|
-4.79 Million USD
|
-71.173%
|
Allakos Inc.
|
-185.7 Million USD
|
95.583%
|
scPharmaceuticals Inc.
|
-54.81 Million USD
|
85.036%
|
Fulcrum Therapeutics, Inc.
|
-97.33 Million USD
|
91.574%
|
Corcept Therapeutics Incorporated
|
106.14 Million USD
|
107.727%
|
NLS Pharmaceutics AG
|
-12.17 Million USD
|
32.618%
|
Precigen, Inc.
|
-95.9 Million USD
|
91.448%
|
XOMA Corporation
|
-40.83 Million USD
|
79.913%
|
Kezar Life Sciences, Inc.
|
-101.87 Million USD
|
91.949%
|
Incyte Corporation
|
597.59 Million USD
|
101.372%
|
Alzamend Neuro, Inc.
|
-9.94 Million USD
|
17.552%
|
Cara Therapeutics, Inc.
|
-118.51 Million USD
|
93.079%
|
Aligos Therapeutics, Inc.
|
-87.67 Million USD
|
90.646%
|
Seer, Inc.
|
-86.27 Million USD
|
90.494%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-24.33 Million USD
|
66.303%
|
CRISPR Therapeutics AG
|
-153.61 Million USD
|
94.661%
|
Akero Therapeutics, Inc.
|
-151.75 Million USD
|
94.596%
|
Eliem Therapeutics, Inc.
|
-35.11 Million USD
|
76.646%
|
EyeGate Pharmaceuticals, Inc.
|
-8.09 Million USD
|
-1.356%
|
Akari Therapeutics, Plc
|
-10 Million USD
|
18.049%
|
Novavax, Inc.
|
-545.06 Million USD
|
98.495%
|
Lexaria Bioscience Corp.
|
-6.66 Million USD
|
-23.058%
|
UroGen Pharma Ltd.
|
-102.24 Million USD
|
91.978%
|
Sutro Biopharma, Inc.
|
-106.79 Million USD
|
92.32%
|
Entera Bio Ltd.
|
-8.88 Million USD
|
7.732%
|
Lisata Therapeutics, Inc.
|
-20.84 Million USD
|
60.644%
|
Stoke Therapeutics, Inc.
|
-104.69 Million USD
|
92.166%
|
Chimerix, Inc.
|
-82.09 Million USD
|
90.009%
|
Reneo Pharmaceuticals, Inc.
|
-77.38 Million USD
|
89.402%
|
Phathom Pharmaceuticals, Inc.
|
-201.59 Million USD
|
95.932%
|
Outlook Therapeutics, Inc.
|
-58.98 Million USD
|
86.095%
|
Jazz Pharmaceuticals plc
|
414.83 Million USD
|
101.977%
|
AnaptysBio, Inc.
|
-163.61 Million USD
|
94.987%
|
Aprea Therapeutics, Inc.
|
-14.28 Million USD
|
42.592%
|
Portage Biotech Inc.
|
-75.33 Million USD
|
89.114%
|
Olema Pharmaceuticals, Inc.
|
-96.65 Million USD
|
91.514%
|
PMV Pharmaceuticals, Inc.
|
-68.96 Million USD
|
88.107%
|
OKYO Pharma Limited
|
-16.82 Thousand USD
|
-48645.788%
|
Qualigen Therapeutics, Inc.
|
-13.41 Million USD
|
38.872%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-8.35 Million USD
|
1.859%
|
Processa Pharmaceuticals, Inc.
|
-11.12 Million USD
|
26.254%
|
AbCellera Biologics Inc.
|
-146.39 Million USD
|
94.398%
|
Genprex, Inc.
|
-30.86 Million USD
|
73.423%
|
Neumora Therapeutics, Inc. Common Stock
|
-235.92 Million USD
|
96.524%
|
NLS Pharmaceutics AG
|
-12.17 Million USD
|
32.618%
|
Virios Therapeutics, Inc.
|
-5.29 Million USD
|
-54.866%
|
Daré Bioscience, Inc.
|
-30.16 Million USD
|
72.807%
|
Titan Pharmaceuticals, Inc.
|
-5.56 Million USD
|
-47.274%
|
Bicycle Therapeutics plc
|
-180.66 Million USD
|
95.46%
|
Revolution Medicines, Inc. Warrant
|
-436.36 Million USD
|
98.12%
|
Protagonist Therapeutics, Inc.
|
-78.95 Million USD
|
89.612%
|
Erasca, Inc.
|
-125.04 Million USD
|
93.441%
|
bluebird bio, Inc.
|
-211.91 Million USD
|
96.13%
|
Pieris Pharmaceuticals, Inc.
|
-24.54 Million USD
|
66.582%
|
BioMarin Pharmaceutical Inc.
|
167.64 Million USD
|
104.892%
|
DBV Technologies S.A.
|
-72.72 Million USD
|
88.722%
|
Fortress Biotech, Inc.
|
-60.63 Million USD
|
86.474%
|
Avidity Biosciences, Inc.
|
-212.22 Million USD
|
96.135%
|
CorMedix Inc.
|
-46.33 Million USD
|
82.301%
|
Travere Therapeutics, Inc.
|
-111.39 Million USD
|
92.638%
|
Sensei Biotherapeutics, Inc.
|
-34.1 Million USD
|
75.949%
|
Orchestra BioMed Holdings, Inc.
|
-49.12 Million USD
|
83.303%
|
Spruce Biosciences, Inc.
|
-47.91 Million USD
|
82.884%
|
Celldex Therapeutics, Inc.
|
-141.42 Million USD
|
94.201%
|
Cartesian Therapeutics, Inc.
|
-219.71 Million USD
|
96.267%
|
Cogent Biosciences, Inc.
|
-192.41 Million USD
|
95.737%
|
Onconetix, Inc.
|
-37.4 Million USD
|
78.076%
|
Ocuphire Pharma, Inc.
|
-9.98 Million USD
|
17.868%
|
Prime Medicine, Inc.
|
-198.13 Million USD
|
95.861%
|
Adagene Inc.
|
-18.94 Million USD
|
56.711%
|
Inhibrx Biosciences, Inc.
|
-241.36 Million USD
|
96.602%
|
GlycoMimetics, Inc.
|
-36.89 Million USD
|
77.773%
|
Maravai LifeSciences Holdings, Inc.
|
-119.02 Million USD
|
93.109%
|
Verve Therapeutics, Inc.
|
-200.06 Million USD
|
95.901%
|
Voyager Therapeutics, Inc.
|
132.33 Million USD
|
106.198%
|
SciSparc Ltd.
|
-5.12 Million USD
|
-60.127%
|
Revelation Biosciences, Inc.
|
-120.25 Thousand USD
|
-6720.316%
|
Minerva Neurosciences, Inc.
|
-30 Million USD
|
72.666%
|
Astria Therapeutics, Inc.
|
-72.89 Million USD
|
88.748%
|
Spero Therapeutics, Inc.
|
22.8 Million USD
|
135.963%
|
Tevogen Bio Holdings Inc.
|
-67.32 Thousand USD
|
-12082.255%
|
Arcutis Biotherapeutics, Inc.
|
-262.14 Million USD
|
96.871%
|
Marker Therapeutics, Inc.
|
-14.04 Million USD
|
41.608%
|
Alnylam Pharmaceuticals, Inc.
|
-440.24 Million USD
|
98.137%
|
Artelo Biosciences, Inc.
|
-9.87 Million USD
|
16.936%
|
2seventy bio, Inc.
|
-217.57 Million USD
|
96.23%
|
ADMA Biologics, Inc.
|
-28.23 Million USD
|
70.956%
|
Clene Inc.
|
-49.5 Million USD
|
83.432%
|
Capricor Therapeutics, Inc.
|
-22.28 Million USD
|
63.201%
|
Boundless Bio, Inc. Common Stock
|
-49.43 Million USD
|
83.409%
|
Recursion Pharmaceuticals, Inc.
|
-328.06 Million USD
|
97.5%
|
Citius Pharmaceuticals, Inc.
|
-32.54 Million USD
|
74.797%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
22.72 Million USD
|
136.099%
|
Absci Corporation
|
-110.56 Million USD
|
92.582%
|
Regeneron Pharmaceuticals, Inc.
|
3.95 Billion USD
|
100.207%
|
Surrozen, Inc.
|
-43.04 Million USD
|
80.945%
|
Caribou Biosciences, Inc.
|
-102.07 Million USD
|
91.965%
|
Janux Therapeutics, Inc.
|
-58.29 Million USD
|
85.93%
|
Cingulate Inc.
|
-23.53 Million USD
|
65.151%
|
Galmed Pharmaceuticals Ltd.
|
-6.91 Million USD
|
-18.659%
|
Tenax Therapeutics, Inc.
|
-7.71 Million USD
|
-6.368%
|
Jaguar Health, Inc.
|
-41.3 Million USD
|
80.141%
|
Terns Pharmaceuticals, Inc.
|
-90.21 Million USD
|
90.908%
|
ACADIA Pharmaceuticals Inc.
|
-61.28 Million USD
|
86.617%
|
Kronos Bio, Inc.
|
-112.67 Million USD
|
92.721%
|
Innoviva, Inc.
|
179.72 Million USD
|
104.564%
|
Bolt Biotherapeutics, Inc.
|
-69.19 Million USD
|
88.147%
|
Entrada Therapeutics, Inc.
|
-6.68 Million USD
|
-22.688%
|
ZyVersa Therapeutics, Inc.
|
-98.29 Million USD
|
91.656%
|
Soligenix, Inc.
|
-6.14 Million USD
|
-33.562%
|
AlloVir, Inc.
|
-190.41 Million USD
|
95.693%
|
Century Therapeutics, Inc.
|
-136.67 Million USD
|
93.999%
|
ORIC Pharmaceuticals, Inc.
|
-100.69 Million USD
|
91.855%
|
Kura Oncology, Inc.
|
-152.63 Million USD
|
94.626%
|
Ocean Biomedical, Inc.
|
565.47 Thousand USD
|
1550.422%
|
Mineralys Therapeutics, Inc.
|
-71.89 Million USD
|
88.593%
|
Eterna Therapeutics Inc.
|
-21.66 Million USD
|
62.148%
|
SELLAS Life Sciences Group, Inc.
|
-37.34 Million USD
|
78.035%
|
Heron Therapeutics, Inc.
|
-110.55 Million USD
|
92.582%
|
SAB Biotherapeutics, Inc.
|
-42.19 Million USD
|
80.562%
|
Pasithea Therapeutics Corp.
|
-15.96 Million USD
|
48.616%
|
Entero Therapeutics, Inc.
|
-15.79 Million USD
|
48.074%
|
HCW Biologics Inc.
|
-24.99 Million USD
|
67.186%
|
C4 Therapeutics, Inc.
|
-132.49 Million USD
|
93.81%
|
Atara Biotherapeutics, Inc.
|
-276.12 Million USD
|
97.03%
|
Coherus BioSciences, Inc.
|
-237.89 Million USD
|
96.552%
|
Lantern Pharma Inc.
|
-15.96 Million USD
|
48.616%
|
Histogen Inc.
|
-10.62 Million USD
|
22.778%
|
Surrozen, Inc.
|
-43.04 Million USD
|
80.945%
|
Eledon Pharmaceuticals, Inc.
|
-40.32 Million USD
|
79.662%
|
Kodiak Sciences Inc.
|
-260.49 Million USD
|
96.851%
|
MoonLake Immunotherapeutics
|
-36 Million USD
|
77.222%
|
Hepion Pharmaceuticals, Inc.
|
-48.92 Million USD
|
83.237%
|
Adverum Biotechnologies, Inc.
|
-117.16 Million USD
|
93.0%
|
Avalo Therapeutics, Inc.
|
-31.54 Million USD
|
73.999%
|
Moderna, Inc.
|
-4.71 Billion USD
|
99.826%
|
Ionis Pharmaceuticals, Inc.
|
-366.28 Million USD
|
97.761%
|
Turnstone Biologics Corp.
|
-55.2 Million USD
|
85.142%
|
Immix Biopharma, Inc.
|
-15.42 Million USD
|
46.832%
|
Tiziana Life Sciences Ltd
|
-16.2 Million USD
|
49.397%
|
Aurinia Pharmaceuticals Inc.
|
-78.02 Million USD
|
89.488%
|
Exelixis, Inc.
|
207.76 Million USD
|
103.948%
|
Monte Rosa Therapeutics, Inc.
|
-135.35 Million USD
|
93.94%
|
Wave Life Sciences Ltd.
|
-57.51 Million USD
|
85.739%
|
Conduit Pharmaceuticals Inc.
|
-535 Thousand USD
|
-1433.029%
|
Alkermes plc
|
355.75 Million USD
|
102.305%
|
Jasper Therapeutics, Inc.
|
-64.46 Million USD
|
87.277%
|
Arcellx, Inc.
|
-70.69 Million USD
|
88.398%
|
ESSA Pharma Inc.
|
-26.58 Million USD
|
69.146%
|
TNF Pharmaceuticals, Inc.
|
-3.99 Million USD
|
-105.045%
|
Avid Bioservices, Inc.
|
-140.75 Million USD
|
94.173%
|
Insmed Incorporated
|
-749.56 Million USD
|
98.906%
|
Cardiff Oncology, Inc.
|
-41.44 Million USD
|
80.209%
|
Enanta Pharmaceuticals, Inc.
|
-133.81 Million USD
|
93.871%
|
Moolec Science SA
|
-51.78 Million USD
|
84.163%
|
RenovoRx, Inc.
|
-10.23 Million USD
|
19.843%
|
Acumen Pharmaceuticals, Inc.
|
-52.37 Million USD
|
84.339%
|
Geron Corporation
|
-184.12 Million USD
|
95.546%
|
LAVA Therapeutics N.V.
|
-41.97 Million USD
|
80.46%
|
Verrica Pharmaceuticals Inc.
|
-66.99 Million USD
|
87.758%
|
Royalty Pharma plc
|
1.13 Billion USD
|
100.723%
|
OmniAb, Inc.
|
-50.61 Million USD
|
83.797%
|
Alector, Inc.
|
-130.39 Million USD
|
93.71%
|
Atea Pharmaceuticals, Inc.
|
-135.95 Million USD
|
93.967%
|
Mersana Therapeutics, Inc.
|
-171.67 Million USD
|
95.222%
|
Humacyte, Inc.
|
-110.77 Million USD
|
92.596%
|
Structure Therapeutics Inc.
|
-89.62 Million USD
|
90.848%
|
Revance Therapeutics, Inc.
|
-323.98 Million USD
|
97.469%
|
89bio, Inc.
|
-142.18 Million USD
|
94.232%
|
Avenue Therapeutics, Inc.
|
-10.37 Million USD
|
20.963%
|
Aura Biosciences, Inc.
|
-76.4 Million USD
|
89.266%
|
Immunic, Inc.
|
-93.61 Million USD
|
91.239%
|
Veracyte, Inc.
|
-74.4 Million USD
|
88.977%
|
Genelux Corporation
|
-28.29 Million USD
|
71.016%
|
Trevi Therapeutics, Inc.
|
-29.06 Million USD
|
71.782%
|
Adial Pharmaceuticals, Inc.
|
-7 Million USD
|
-17.136%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.83 Million USD
|
56.45%
|
Immunovant, Inc.
|
-259.33 Million USD
|
96.837%
|
Vericel Corporation
|
-3.18 Million USD
|
-157.753%
|
Fortrea Holdings Inc.
|
-3.4 Million USD
|
-141.227%
|
KalVista Pharmaceuticals, Inc.
|
-126.64 Million USD
|
93.524%
|
XBiotech Inc.
|
-24.55 Million USD
|
66.601%
|
Agenus Inc.
|
-245.76 Million USD
|
96.663%
|
Acasti Pharma Inc.
|
-12.85 Million USD
|
36.188%
|
Kiora Pharmaceuticals, Inc.
|
-12.51 Million USD
|
34.459%
|
MiNK Therapeutics, Inc.
|
-22.45 Million USD
|
63.48%
|
Pasithea Therapeutics Corp.
|
-15.96 Million USD
|
48.616%
|
Theravance Biopharma, Inc.
|
-55.19 Million USD
|
85.14%
|
Metagenomi, Inc. Common Stock
|
-68.25 Million USD
|
87.984%
|
NeuroBo Pharmaceuticals, Inc.
|
-12.47 Million USD
|
34.229%
|
Gain Therapeutics, Inc.
|
-22.26 Million USD
|
63.167%
|
Tempest Therapeutics, Inc.
|
-29.49 Million USD
|
72.189%
|
Sol-Gel Technologies Ltd.
|
-27.23 Million USD
|
69.889%
|
Rhythm Pharmaceuticals, Inc.
|
-184.67 Million USD
|
95.559%
|
United Therapeutics Corporation
|
984.8 Million USD
|
100.833%
|
Creative Medical Technology Holdings, Inc.
|
-5.28 Million USD
|
-55.142%
|
BriaCell Therapeutics Corp.
|
-4.79 Million USD
|
-71.173%
|
Lixte Biotechnology Holdings, Inc.
|
-5.08 Million USD
|
-61.228%
|
Silo Pharma, Inc.
|
-3.7 Million USD
|
-121.627%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-13.07 Million USD
|
37.257%
|
Pharming Group N.V.
|
-10.54 Million USD
|
22.244%
|
XOMA Corporation
|
-40.83 Million USD
|
79.913%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-24.33 Million USD
|
66.303%
|
Bionomics Limited
|
-15.49 Billion USD
|
99.947%
|
Alpha Tau Medical Ltd.
|
-29.15 Million USD
|
71.871%
|
Pyxis Oncology, Inc.
|
-73.79 Million USD
|
88.885%
|
uniQure N.V.
|
-308.47 Million USD
|
97.341%
|
Xilio Therapeutics, Inc.
|
-76.4 Million USD
|
89.265%
|
Cassava Sciences, Inc.
|
-97.21 Million USD
|
91.564%
|
60 Degrees Pharmaceuticals, Inc.
|
-3.76 Million USD
|
-117.8%
|
Windtree Therapeutics, Inc.
|
-20.29 Million USD
|
59.58%
|
Poseida Therapeutics, Inc.
|
-123.43 Million USD
|
93.355%
|
Pluri Inc.
|
-20.88 Million USD
|
60.735%
|
MeiraGTx Holdings plc
|
-84.02 Million USD
|
90.239%
|
Cidara Therapeutics, Inc.
|
-22.93 Million USD
|
64.233%
|
ProMIS Neurosciences, Inc.
|
-17.5 Million USD
|
53.15%
|
CalciMedica, Inc.
|
-34.35 Million USD
|
76.128%
|
Sana Biotechnology, Inc.
|
-283.25 Million USD
|
97.104%
|
Amicus Therapeutics, Inc.
|
-151.58 Million USD
|
94.589%
|
Salarius Pharmaceuticals, Inc.
|
-12.54 Thousand USD
|
-65290.303%
|
Alpha Tau Medical Ltd.
|
-29.15 Million USD
|
71.871%
|
Adlai Nortye Ltd. American Depositary Shares
|
-104.87 Million USD
|
92.179%
|
Nutriband Inc.
|
-5.48 Million USD
|
-49.521%
|
Protara Therapeutics, Inc.
|
-40.42 Million USD
|
79.709%
|
Compugen Ltd.
|
-18.75 Million USD
|
56.267%
|
Roivant Sciences Ltd.
|
4.34 Billion USD
|
100.189%
|
ProKidney Corp.
|
-35.46 Million USD
|
76.876%
|
Protagenic Therapeutics, Inc.
|
-5 Million USD
|
-64.018%
|
Elevai Labs, Inc. Common Stock
|
-4.3 Million USD
|
-90.67%
|
Tango Therapeutics, Inc.
|
-101.74 Million USD
|
91.939%
|
Renovaro Biosciences Inc.
|
-80.65 Million USD
|
89.831%
|
Zevra Therapeutics, Inc.
|
-46.04 Million USD
|
82.189%
|
Benitec Biopharma Inc.
|
-21.75 Million USD
|
62.293%
|
GeoVax Labs, Inc.
|
-25.96 Million USD
|
68.415%
|
Biomea Fusion, Inc.
|
-117.25 Million USD
|
93.005%
|
Cullinan Oncology, Inc.
|
-153.16 Million USD
|
94.645%
|
4D Molecular Therapeutics, Inc.
|
-100.83 Million USD
|
91.866%
|
Kiniksa Pharmaceuticals, Ltd.
|
14.08 Million USD
|
158.234%
|
Nuvectis Pharma, Inc.
|
-22.26 Million USD
|
63.155%
|
Spyre Therapeutics, Inc.
|
-338.79 Million USD
|
97.579%
|
Ventyx Biosciences, Inc.
|
-192.96 Million USD
|
95.75%
|
Imunon, Inc.
|
-19.51 Million USD
|
57.972%
|
BioAtla, Inc.
|
-123.46 Million USD
|
93.357%
|
Allogene Therapeutics, Inc.
|
-327.26 Million USD
|
97.494%
|
Larimar Therapeutics, Inc.
|
-36.94 Million USD
|
77.803%
|
Zura Bio Limited
|
-60.36 Million USD
|
86.412%
|
aTyr Pharma, Inc.
|
-50.38 Million USD
|
83.723%
|
Madrigal Pharmaceuticals, Inc.
|
-373.63 Million USD
|
97.805%
|
Viridian Therapeutics, Inc.
|
-237.73 Million USD
|
96.55%
|
Galecto, Inc.
|
-38.34 Million USD
|
78.613%
|
Tevogen Bio Holdings Inc.
|
-67.32 Thousand USD
|
-12082.255%
|
Halozyme Therapeutics, Inc.
|
281.59 Million USD
|
102.913%
|
Lexicon Pharmaceuticals, Inc.
|
-177.11 Million USD
|
95.369%
|
PolyPid Ltd.
|
-23.86 Million USD
|
65.633%
|
Aileron Therapeutics, Inc.
|
-15.73 Million USD
|
47.866%
|
Forte Biosciences, Inc.
|
-31.47 Million USD
|
73.943%
|
Xencor, Inc.
|
-126.08 Million USD
|
93.495%
|
Coeptis Therapeutics Holdings, Inc.
|
-21.26 Million USD
|
61.434%
|
Lexaria Bioscience Corp.
|
-6.66 Million USD
|
-23.058%
|
Instil Bio, Inc.
|
-156.08 Million USD
|
94.745%
|
Cardio Diagnostics Holdings, Inc.
|
-8.37 Million USD
|
2.091%
|
OncoCyte Corporation
|
-27.78 Million USD
|
70.477%
|
Elevation Oncology, Inc.
|
-45.7 Million USD
|
82.055%
|
Purple Biotech Ltd.
|
-19.88 Million USD
|
58.744%
|
CollPlant Biotechnologies Ltd.
|
-7.01 Million USD
|
-16.85%
|
MacroGenics, Inc.
|
-9.05 Million USD
|
9.453%
|
Verona Pharma plc
|
-54.36 Million USD
|
84.915%
|
Tharimmune, Inc.
|
-9.31 Million USD
|
11.99%
|
Apogee Therapeutics, Inc.
|
-83.98 Million USD
|
90.234%
|
enGene Holdings Inc. Warrants
|
-99.91 Million USD
|
91.791%
|
Aditxt, Inc.
|
-32.38 Million USD
|
74.671%
|
XTL Biopharmaceuticals Ltd.
|
-1.78 Million USD
|
-360.253%
|
Savara Inc.
|
-54.69 Million USD
|
85.005%
|
Curis, Inc.
|
-47.41 Million USD
|
82.702%
|
Carmell Therapeutics Corporation
|
-15.44 Million USD
|
46.898%
|
Achieve Life Sciences, Inc.
|
-29.81 Million USD
|
72.491%
|
BeiGene, Ltd.
|
-881.7 Million USD
|
99.07%
|
Protagenic Therapeutics, Inc.
|
-5 Million USD
|
-64.018%
|
Vincerx Pharma, Inc.
|
-40.15 Million USD
|
79.576%
|
Plus Therapeutics, Inc.
|
-13.31 Million USD
|
38.407%
|
Acrivon Therapeutics, Inc. Common Stock
|
-60.38 Million USD
|
86.418%
|
Rigel Pharmaceuticals, Inc.
|
-25.09 Million USD
|
67.312%
|
Adicet Bio, Inc.
|
-142.65 Million USD
|
94.251%
|
Estrella Immunopharma, Inc.
|
-7.31 Million USD
|
-12.172%
|
Quantum-Si incorporated
|
-95.96 Million USD
|
91.453%
|
Acurx Pharmaceuticals, Inc.
|
-14.57 Million USD
|
43.738%
|
Generation Bio Co.
|
-126.61 Million USD
|
93.522%
|
Black Diamond Therapeutics, Inc.
|
-82.44 Million USD
|
90.052%
|
Invivyd, Inc.
|
-198.64 Million USD
|
95.871%
|
Relay Therapeutics, Inc.
|
-341.97 Million USD
|
97.602%
|
Quoin Pharmaceuticals, Ltd.
|
-8.68 Million USD
|
5.582%
|
Moolec Science SA
|
-51.78 Million USD
|
84.163%
|
Clearside Biomedical, Inc.
|
-32.48 Million USD
|
74.752%
|
Longboard Pharmaceuticals, Inc.
|
-54.42 Million USD
|
84.929%
|
Relmada Therapeutics, Inc.
|
-98.79 Million USD
|
91.698%
|
ALX Oncology Holdings Inc.
|
-160.8 Million USD
|
94.9%
|
Vir Biotechnology, Inc.
|
-615.06 Million USD
|
98.667%
|
Evaxion Biotech A/S
|
-22.12 Million USD
|
62.93%
|
Ocular Therapeutix, Inc.
|
-80.73 Million USD
|
89.841%
|
Tyra Biosciences, Inc.
|
-69.13 Million USD
|
88.137%
|
Unity Biotechnology, Inc.
|
-39.86 Million USD
|
79.424%
|
Connect Biopharma Holdings Limited
|
-59.5 Million USD
|
86.216%
|
Clearmind Medicine Inc.
|
-11.95 Million USD
|
31.395%
|
Aadi Bioscience, Inc.
|
-65.76 Million USD
|
87.529%
|
Catalyst Pharmaceuticals, Inc.
|
71.41 Million USD
|
111.485%
|
CERo Therapeutics Holdings, Inc.
|
-2536.23 USD
|
-323281.673%
|
Viking Therapeutics, Inc.
|
-85.89 Million USD
|
90.451%
|
Keros Therapeutics, Inc.
|
-152.99 Million USD
|
94.639%
|
Crinetics Pharmaceuticals, Inc.
|
-214.52 Million USD
|
96.177%
|
ImmunityBio, Inc.
|
-583.19 Million USD
|
98.594%
|
Korro Bio, Inc.
|
-81.17 Million USD
|
89.896%
|
Kineta, Inc.
|
-14.09 Million USD
|
41.828%
|
BioVie Inc.
|
-32.12 Million USD
|
74.466%
|
Codexis, Inc.
|
-76.24 Million USD
|
89.242%
|
Celularity Inc.
|
-196.29 Million USD
|
95.822%
|
Virax Biolabs Group Limited
|
-6.73 Million USD
|
-21.804%
|
Cibus, Inc.
|
-267.62 Million USD
|
96.935%
|
Annexon, Inc.
|
-134.23 Million USD
|
93.89%
|
Assembly Biosciences, Inc.
|
-61.22 Million USD
|
86.605%
|
Eyenovia, Inc.
|
-27.26 Million USD
|
69.914%
|
Puma Biotechnology, Inc.
|
21.59 Million USD
|
137.987%
|
NeurAxis, Inc.
|
-14.62 Million USD
|
43.926%
|
Regulus Therapeutics Inc.
|
-30.03 Million USD
|
72.695%
|
Compass Therapeutics, Inc.
|
-42.49 Million USD
|
80.699%
|
TFF Pharmaceuticals, Inc.
|
-21.24 Million USD
|
61.391%
|
Notable Labs, Ltd.
|
-11.26 Million USD
|
27.187%
|
IN8bio, Inc.
|
-30 Million USD
|
72.667%
|
DiaMedica Therapeutics Inc.
|
-19.38 Million USD
|
57.682%
|
Vera Therapeutics, Inc.
|
-95.99 Million USD
|
91.456%
|
Lumos Pharma, Inc.
|
-34.03 Million USD
|
75.901%
|
Liquidia Corporation
|
-78.5 Million USD
|
89.552%
|
Mustang Bio, Inc.
|
-51.6 Million USD
|
84.106%
|
Quantum-Si incorporated
|
-95.96 Million USD
|
91.453%
|
Arbutus Biopharma Corporation
|
-72.84 Million USD
|
88.742%
|
enGene Holdings Inc. Common Stock
|
-99.91 Million USD
|
91.791%
|
ARS Pharmaceuticals, Inc.
|
-54.36 Million USD
|
84.914%
|
180 Life Sciences Corp.
|
-19.93 Million USD
|
58.858%
|
Vaxcyte, Inc.
|
-402.26 Million USD
|
97.961%
|
Xenon Pharmaceuticals Inc.
|
-182.39 Million USD
|
95.503%
|
Estrella Immunopharma, Inc.
|
-7.31 Million USD
|
-12.172%
|
NKGen Biotech, Inc. Warrants
|
-82.95 Million USD
|
90.113%
|
Opiant Pharmaceuticals, Inc.
|
3 Million USD
|
372.591%
|
CERo Therapeutics Holdings, Inc.
|
-2536.23 USD
|
-323281.673%
|
Soleno Therapeutics, Inc.
|
-38.98 Million USD
|
78.964%
|
PepGen Inc.
|
-78.62 Million USD
|
89.569%
|
Moleculin Biotech, Inc.
|
-29.76 Million USD
|
72.449%
|
Solid Biosciences Inc.
|
-96.01 Million USD
|
91.458%
|
Palisade Bio, Inc.
|
-12.3 Million USD
|
33.319%
|
Nutriband Inc.
|
-5.48 Million USD
|
-49.521%
|
Conduit Pharmaceuticals Inc.
|
-535 Thousand USD
|
-1433.029%
|
Immuneering Corporation
|
-53.47 Million USD
|
84.662%
|
Belite Bio, Inc
|
-31.63 Million USD
|
74.072%
|
CG Oncology, Inc. Common stock
|
-48.6 Million USD
|
83.126%
|
GeoVax Labs, Inc.
|
-25.96 Million USD
|
68.415%
|
Tourmaline Bio, Inc.
|
-42.12 Million USD
|
80.53%
|
Altimmune, Inc.
|
-88.44 Million USD
|
90.727%
|
Peak Bio, Inc.
|
-1259.26 USD
|
-651211.326%
|
SeaStar Medical Holding Corporation
|
-26.23 Million USD
|
68.734%
|
FibroBiologics, Inc. Common Stock
|
-16.48 Million USD
|
50.247%
|
Neurogene Inc.
|
-36.31 Million USD
|
77.416%
|
Mirum Pharmaceuticals, Inc.
|
-163.41 Million USD
|
94.981%
|
Kintara Therapeutics, Inc.
|
-8.5 Million USD
|
3.521%
|
CARGO Therapeutics, Inc. Common Stock
|
-98.14 Million USD
|
91.643%
|
Sesen Bio, Inc.
|
-19.88 Million USD
|
58.752%
|
argenx SE
|
-295.05 Million USD
|
97.22%
|
NKGen Biotech, Inc. Common Stock
|
-82.95 Million USD
|
90.113%
|
Dianthus Therapeutics, Inc.
|
-43.55 Million USD
|
81.169%
|
Immunome, Inc.
|
-106.8 Million USD
|
92.321%
|
Enveric Biosciences, Inc.
|
-17.29 Thousand USD
|
-47331.362%
|
Design Therapeutics, Inc.
|
-66.86 Million USD
|
87.733%
|
Seelos Therapeutics, Inc.
|
-37.88 Million USD
|
78.349%
|
Enliven Therapeutics, Inc.
|
-71.58 Million USD
|
88.543%
|
Iovance Biotherapeutics, Inc.
|
-444.03 Million USD
|
98.153%
|
Taysha Gene Therapies, Inc.
|
-111.56 Million USD
|
92.649%
|
Inovio Pharmaceuticals, Inc.
|
-135.11 Million USD
|
93.93%
|
Athira Pharma, Inc.
|
-117.67 Million USD
|
93.03%
|
XOMA Corporation
|
-40.83 Million USD
|
79.913%
|
Merus N.V.
|
-154.93 Million USD
|
94.706%
|
Quince Therapeutics, Inc.
|
-31.38 Million USD
|
73.867%
|
Rezolute, Inc.
|
-68.45 Million USD
|
88.02%
|
Clene Inc.
|
-49.5 Million USD
|
83.432%
|
Indaptus Therapeutics, Inc.
|
-15.42 Million USD
|
46.823%
|
BeyondSpring Inc.
|
-21.02 Million USD
|
60.993%
|
Synlogic, Inc.
|
-57.28 Million USD
|
85.682%
|
Allarity Therapeutics, Inc.
|
-11.9 Million USD
|
31.084%
|
Phio Pharmaceuticals Corp.
|
-10.82 Million USD
|
24.241%
|
Peak Bio, Inc.
|
-1259.26 USD
|
-651211.326%
|
Werewolf Therapeutics, Inc.
|
-37.36 Million USD
|
78.052%
|
Krystal Biotech, Inc.
|
10.93 Million USD
|
175.025%
|
Karyopharm Therapeutics Inc.
|
-143.09 Million USD
|
94.269%
|
SpringWorks Therapeutics, Inc.
|
-325.1 Million USD
|
97.477%
|
Lipella Pharmaceuticals Inc.
|
-4.61 Million USD
|
-77.566%
|
MannKind Corporation
|
-11.93 Million USD
|
31.298%
|
Ikena Oncology, Inc.
|
-68.16 Million USD
|
87.968%
|
Cyclerion Therapeutics, Inc.
|
-21.01 Million USD
|
60.972%
|
Gyre Therapeutics, Inc.
|
-92.93 Million USD
|
91.175%
|
Gossamer Bio, Inc.
|
-179.81 Million USD
|
95.439%
|
CohBar, Inc.
|
-11.96 Million USD
|
31.436%
|
Cognition Therapeutics, Inc.
|
-25.78 Million USD
|
68.196%
|
NRx Pharmaceuticals, Inc.
|
-30.15 Million USD
|
72.797%
|
Legend Biotech Corporation
|
-518.25 Million USD
|
98.417%
|
Mural Oncology plc
|
-207.44 Million USD
|
96.046%
|
Disc Medicine, Inc.
|
-76.42 Million USD
|
89.269%
|
Champions Oncology, Inc.
|
-7.27 Million USD
|
-12.723%
|
REGENXBIO Inc.
|
-263.49 Million USD
|
96.887%
|
Ensysce Biosciences, Inc.
|
-10.61 Million USD
|
22.721%
|
Anavex Life Sciences Corp.
|
-47.5 Million USD
|
82.735%
|
Cellectar Biosciences, Inc.
|
-37.98 Million USD
|
78.407%
|
Edgewise Therapeutics, Inc.
|
-100.16 Million USD
|
91.812%
|
Vaxart, Inc.
|
-82.46 Million USD
|
90.054%
|
PharmaCyte Biotech, Inc.
|
333.76 Thousand USD
|
2557.343%
|
Aldeyra Therapeutics, Inc.
|
-37.54 Million USD
|
78.154%
|
Cellectis S.A.
|
-101.05 Million USD
|
91.884%
|
Longeveron Inc.
|
-21.41 Million USD
|
61.698%
|
Repare Therapeutics Inc.
|
-93.79 Million USD
|
91.256%
|
Sarepta Therapeutics, Inc.
|
-535.97 Million USD
|
98.47%
|
Inozyme Pharma, Inc.
|
-71.16 Million USD
|
88.476%
|
Revolution Medicines, Inc.
|
-436.36 Million USD
|
98.12%
|
Nymox Pharmaceutical Corporation
|
-6.57 Million USD
|
-24.817%
|
Third Harmonic Bio, Inc.
|
-30.82 Million USD
|
73.392%
|
ArriVent BioPharma, Inc. Common Stock
|
-69.33 Million USD
|
88.171%
|
AN2 Therapeutics, Inc.
|
-64.73 Million USD
|
87.33%
|
Anixa Biosciences, Inc.
|
-9.81 Million USD
|
16.403%
|
Vertex Pharmaceuticals Incorporated
|
3.61 Billion USD
|
100.227%
|
Denali Therapeutics Inc.
|
-145.22 Million USD
|
94.352%
|
Revelation Biosciences, Inc.
|
-120.25 Thousand USD
|
-6720.316%
|
Veru Inc.
|
-93.15 Million USD
|
91.195%
|
Corvus Pharmaceuticals, Inc.
|
-27.02 Million USD
|
69.656%
|
Cingulate Inc.
|
-23.53 Million USD
|
65.151%
|
Passage Bio, Inc.
|
-102.06 Million USD
|
91.964%
|
Context Therapeutics Inc.
|
-23.96 Million USD
|
65.775%
|
Exicure, Inc.
|
-16.91 Million USD
|
51.509%
|
Day One Biopharmaceuticals, Inc.
|
-188.91 Million USD
|
95.659%
|
Oramed Pharmaceuticals Inc.
|
-37.76 Million USD
|
78.282%
|
Scinai Immunotherapeutics Ltd.
|
-6.5 Million USD
|
-26.038%
|
Nuvalent, Inc.
|
-126.21 Million USD
|
93.502%
|
ABVC BioPharma, Inc.
|
-10.51 Million USD
|
22.005%
|
Carisma Therapeutics, Inc.
|
-86.87 Million USD
|
90.56%
|
Unicycive Therapeutics, Inc.
|
-30.54 Million USD
|
73.148%
|
OmniAb, Inc.
|
-50.61 Million USD
|
83.797%
|
Anew Medical, Inc.
|
1.34 Million USD
|
709.282%
|
Fennec Pharmaceuticals Inc.
|
-16.04 Million USD
|
48.883%
|
Lipocine Inc.
|
-16.35 Million USD
|
49.843%
|
Lexeo Therapeutics, Inc. Common Stock
|
-66.39 Million USD
|
87.647%
|
Nautilus Biotechnology, Inc.
|
-63.67 Million USD
|
87.119%
|
SAB Biotherapeutics, Inc.
|
-42.19 Million USD
|
80.562%
|
G1 Therapeutics, Inc.
|
-47.96 Million USD
|
82.901%
|
Bellerophon Therapeutics, Inc.
|
-19.83 Million USD
|
58.642%
|
Sage Therapeutics, Inc.
|
-541.48 Million USD
|
98.485%
|
Ocugen, Inc.
|
-63.07 Million USD
|
86.998%
|
Mind Medicine (MindMed) Inc.
|
-95.73 Million USD
|
91.433%
|
Q32 Bio Inc.
|
-112.96 Million USD
|
92.739%
|
Brainstorm Cell Therapeutics Inc.
|
-17.19 Million USD
|
52.293%
|
Alumis Inc. Common Stock
|
-154.99 Million USD
|
94.708%
|
Equillium, Inc.
|
-13.33 Million USD
|
38.495%
|
Kyverna Therapeutics, Inc.
|
-60.36 Million USD
|
86.413%
|
Coya Therapeutics, Inc.
|
-7.98 Million USD
|
-2.677%
|
CNS Pharmaceuticals, Inc.
|
-18.85 Million USD
|
56.492%
|
Dominari Holdings Inc.
|
-22.88 Million USD
|
64.157%
|
Edesa Biotech, Inc.
|
-8.37 Million USD
|
2.062%
|
vTv Therapeutics Inc.
|
-20.25 Million USD
|
59.498%
|
Bio-Techne Corporation
|
168.1 Million USD
|
104.879%
|
Agios Pharmaceuticals, Inc.
|
-352.08 Million USD
|
97.671%
|
Harmony Biosciences Holdings, Inc.
|
128.85 Million USD
|
106.365%
|
Prelude Therapeutics Incorporated
|
-121.83 Million USD
|
93.268%
|
Candel Therapeutics, Inc.
|
-37.93 Million USD
|
78.382%
|
iTeos Therapeutics, Inc.
|
-112.64 Million USD
|
92.719%
|
Nkarta, Inc.
|
-117.5 Million USD
|
93.02%
|
BioCardia, Inc.
|
-11.57 Million USD
|
29.118%
|
Iterum Therapeutics plc
|
-38.37 Million USD
|
78.625%
|